FDA Letter to Sunovion Misleading Marketing
Misleading Marketing of Respiratory Drug Brovana. In a letter released on Tuesday, the U.S. Food and Drug Administration (FDA) charges that Sunovion Pharmaceuticals Inc. deceptively promoted its respiratory drug Brovana (arformoterol), minimizing the drug’s risks and exaggerating its effectiveness. According to the letter, the FDA … [Read more...] about FDA Letter to Sunovion Misleading Marketing
Deceptive Promotions Used by Sunovion to Hype Respiratory Drug Brovana, FDA Charges
Respiratory Drug Brovana Misleading Material. Parker Waichman LLP is investigating a potential class action lawsuit on behalf of patients who took Sunovion, a respiratory drug that federal health officials charge was promoted to the public with misleading material. Marlborough, Mass.-based Sunovion Pharmaceuticals Inc., a unit of … [Read more...] about Deceptive Promotions Used by Sunovion to Hype Respiratory Drug Brovana, FDA Charges
